methionine has been researched along with dapagliflozin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, E; Jo, HA; Kim, DJ; Kim, DK; Kim, YS; Lee, S; Seo, JH; Yang, SH; Yu, MY | 1 |
| Abramovich, I; Agranovich, B; Ben-Haroush Schyr, R; Ben-Zvi, D; Bernal-Mizrachi, E; Cerasi, E; Gottlieb, E; Hinden, L; Kadosh, L; Kleiman, D; Kogot-Levin, A; Leibowitz, G; Mosenzon, O; Riahi, Y; Tam, J | 1 |
2 other study(ies) available for methionine and dapagliflozin
| Article | Year |
|---|---|
Metabolomic profiling in kidney cells treated with a sodium glucose-cotransporter 2 inhibitor.
Topics: Arginine; Asparagine; Epithelial Cells; Glucose; Glutathione; Histidine; Humans; Isoleucine; Kidney; Lysine; Metabolomics; Methionine; Phenylalanine; Proline; Sodium; Sodium-Glucose Transporter 2; Threonine | 2023 |
Mapping the metabolic reprogramming induced by sodium-glucose cotransporter 2 inhibition.
Topics: AMP-Activated Protein Kinases; Animals; Betaine; Diabetes Mellitus, Experimental; Glucose; Methionine; Mice; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2023 |